Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill?*

Abstract

Critically ill patients with normal renal function demonstrated significantly lower anti-Xa levels in response to a single daily dose of subcutaneous enoxaparin when compared with medical patients in the normal ward.